Keywords: merck, serono, erbitux, nominated, prix, galien, german

Merck Serono's Erbitux nominated for Prix Galien

Article | 20 October 2008

Print This

German drug major Merck Serono's Erbitux (cetuximab) is one of the finalists for the prestigious International Prix Galien Award for ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in